Transient elastography and aspartate aminotransferase to platelet ratio predict liver injury in paediatric intestinal

Maria Hukkinen1, Reetta Kivisaari2, Jouko Lohi3

  • 1Pediatric Liver and Gut Research Group, Children's Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Insights

Transient elastography (TE) and AST to platelet ratio (APRI) can predict liver disease in children with intestinal failure (IF). TE better predicts fibrosis, while APRI is more accurate for cholestasis.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Noninvasive Diagnostics

Background:

  • Intestinal failure (IF) often necessitates long-term parenteral nutrition (PN), increasing the risk of liver disease in children.
  • Liver biopsy is invasive; thus, noninvasive methods to assess IF-related liver histopathology are crucial.

Purpose of the Study:

  • To evaluate the diagnostic value of AST to platelet ratio (APRI) and transient elastography (TE) in predicting liver histopathology in pediatric patients with IF.
  • To compare the efficacy of TE and APRI in identifying fibrosis, cholestasis, and steatosis.

Main Methods:

  • Analysis of 93 liver biopsies from 57 children with PN duration of at least 3 months.
  • APRI measurements and TE were performed concurrently with liver biopsies in 46 children.
  • Histopathological findings including fibrosis, cholestasis, and steatosis were correlated with APRI and TE values.

Main Results:

  • Histological liver abnormalities were common, with 61% showing fibrosis, 25% cholestasis, and 22% steatosis.
  • Transient elastography (TE) demonstrated superior performance in predicting overall liver histopathology (AUROC 0.86) compared to APRI (AUROC 0.67).
  • TE accurately predicted fibrosis stages (AUROC ≥F1: 0.78, ≥F2: 0.73), while APRI showed better accuracy for detecting cholestasis (AUROC 0.77).

Conclusions:

  • Both TE and APRI are valuable noninvasive tools for monitoring liver disease progression in children with IF.
  • TE is more effective for assessing liver fibrosis, whereas APRI is more accurate for diagnosing cholestasis.
  • These noninvasive methods can aid in clinical decision-making and reduce the need for liver biopsies.
Abstract